Information processing: Rate-based investigation of cell physiological changes along design space development

PDA Journal of Pharmaceutical Science and Technology

Volumn 66, Issue 6, 2012, Pages 526-541

  Sagmeister, Patrick ^a   Wechselberger, Patrick ^a   Herwig, Christoph ^a  

^a VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

Data processing; Design of experiments; Design space development; Information processing; Multivariate data analysis; Process development; Process optimization; Quality by design

Indexed keywords

CARBON DIOXIDE; PROTEIN;

AIRFLOW; ANALYTICAL PARAMETERS; ARTICLE; BIOMASS; BIOPROCESS; CELL FUNCTION; DATA ANALYSIS; DATA PROCESSING; DESIGN SPACE DEVELOPMENT; DRY WEIGHT; ESCHERICHIA COLI K 12; EXPERIMENTAL DESIGN; FED BATCH FERMENTATION; MOLECULAR BIOLOGY; PROCESS DEVELOPMENT; QUALITY CONTROL; TEMPERATURE MEASUREMENT; HUMAN;

HUMANS; QUALITY CONTROL;

EID: 84873662135     PISSN: 10797440     EISSN: 19482124     Source Type: Journal    
DOI: 10.5731/pdajpst.2012.00889     Document Type: Article

References (42)

1. ICH. Pharmaceutical development. Q8(R2). Current Step 4'. Retrieved July 3, 2012 from http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/ Guidelines/Quality/Q8-R1/Step4/Q8-R2-Guideline.pdf, 2009.
2. U.S. Food and Drug Administration (FDA). Pharmaceutical cGMPs for the 21st Century - A Risk-Based Approach. Retrieved July 3, 2012 fromhttp://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/Manufacturing/ QuestionsandAnswersonCurrentGoodManufacturingPracticescGMPforDrugs/UCM176374. pdf, 2004.
3. ICH. Development and manufacture of drug substances (chemical entities and biotechnological/biological entities) Q11. Retrieved July 3, 2012from http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/Guidelines/Quality/ Q11/Q11-Step-4.pdf, 2012.
4. EMA Guideline on Real Time Release Testing(formerly Guideline on Parametric Release). Retrieved July 3, 2012 from http://www.emea.europa.eu/docs/ en-GB/document-library/Scientific-guideline/2010/03/WC500075028.pdf, 2010.
5. Garcia, T.; Cook, G.; Nosal, R. PQLI key topics - criticality, design space, and control strategy. J. Pharm. Innov. 2008, 3 (2), 60 - 68.
6. Chirino, A. J.; Mire-Sluis, A. Characterizing biological products and assessing comparability following manufacturing changes. Nature Biotechnol. 2004, 22 (11), 1383-1391.
7. Harms, J.; Wang, X.; Kim, T.; Yang, X.; Rathore, A. S. Defining process design space for biotech products: case study of Pichia pastoris fermentation. Biotechnol. Prog. 2008, 24 (3), 655- 662.
8. Rathore, A. S.; Yu, M.; Yeboah, S.; Sharma, A. Case study and application of process analytical technology (PAT) towards bioprocessing: use of on-line high-performance liquid chromatography (HPLC) for making real-time pooling decisions for process chromatography. Biotechnol. Bioeng. 2008, 100 (2), 306 -316.
9. Woelbeling, C. Creating quality by design/process analytical technology (PAT/QbD) management awareness. Pharm. Eng. 2008, 28, 1-9.
10. Yu, L. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm. Res. 2008, 25 (4), 781-791.
11. Huang, J.; Kaul, G.; Cai, C.; Chatlapalli, R.; Hernandez-Abad, P.; Ghosh, K.; Nagi, A. Quality by design case study: An integrated multivariate approach to drug product and process development. Int. J. Pharm. 2009, 382 (1-2), 23-32.
12. Mandenius, C.-F.; Graumann, K.; Schultz, T. W.; Premstaller, A.; Olsson, I. M.; Petiot, E.; Clemens, C.; Welin, M. Quality-by-design for biotechnology-related pharmaceuticals. Biotechnology Journal 2009, 4 (5), 600 - 609.
13. Rathore, A. S. Roadmap for implementation of quality by design (QbD) for biotechnology products. Trends Biotechnol. 2009, 27 (9), 546 -553.
14. Rathore, A. S.; Mhatre, R. Quality by Design for Biopharmaceuticals: Principles and Case Studies; John Wiley & Sons: Hoboken, NJ, 2009.
15. Schmidt-Bader, T. PAT und QbD im regulatorischen Umfeld der Pharmazeutischen Industrie. Chemie Ingenieur Technik 2010, 82, 415- 428.
16. Anurag, P.; Rathore, S.; Branning, R.; Cecchini, D. Quality: design space for biotech products. BioPharm Int. 2007, 20 (4).
17. Winkle, H. Implementing Quality by Design, PDA/FDA Joint Regulatory Conference, Washington, DC. Retrieved July 3, 2012 from http://www.fda.gov/ downloads/AboutFDA/CentersOffices/CDER/ucm103453.pdf, 2012.
18. Ündey, C.; Ertunç, S.; Mistretta, T.; Looze, B. Applied advanced process analytics in biopharmaceutical manufacturing: Challenges and prospects in real-time monitoring and control. J. Process Control 2010, 20 (9), 1009 -1018.
19. Kitano, H. Systems biology: a brief overview. Science 2002, 295, 1662-1664.
20. Striedner, G.; Cserjan-Puschmann, M.; Potschacher, F.; Bayer, K. Tuning the transcription rate of recombinant protein in strong Escherichia coli expression systems through repressor titration. Biotechnol. Prog. 2003, 19 (5), 1427-1432.
21. Wechselberger P.; Herwig, C. Model-based analysis on the relationship of signal quality to realtime extraction of information in bioprocesses. Biotechnol. Prog. 2012, 28 (1), 265-275.
22. Herwig, C.; Marison, I.; von Stockar, U. On-line stoichiometry and identification of metabolic state under dynamic process conditions. Biotechnol. Bioeng. 2001, 75 (3), 345-354.
23. Jazini, M.; Herwig, C. Effect of post-induction substrate oscillation on recombinant alkaline phosphatase production expressed in Escherichia coli. J. Biosci. Bioeng. 2011, 112 (6), 606 - 610.
24. Rozkov, A.; Avignone-Rossa, C. A.; Ertl, P. F.; Jones, P.; O'Kennedy, R. D.; Smith, J. J.; Dale, J. W.; Bushell, M. E. Characterization of the metabolic burden on Escherichia coli DH1 cells imposed by the presence of a plasmid containing a gene therapy sequence. Biotechnol. Bioeng. 2004, 88 (7), 909 -915.
25. Dietzsch, C.; Spadiut, O.; Herwig, C. A dynamic method based on the specific substrate uptake rate to set up a feeding strategy for Pichia pastoris. Microb. Cell Fact. 2011, 10, 14.
26. Dietzsch, C.; Spadiut, O.; Herwig, C. A fast approach to determine a fed batch feeding profile for recombinant Pichia pastoris strains. Microb. Cell Fact. 2011, 10, 85.
27. Wechselberger, P.; Sagmeister, P.; Engelking, H.; Schmidt, T.; Wenger, J. Efficient feeding profile optimization using physiological information. Bioprocess Biosyst. Eng. 2012, in press.
28. Jobé, A. M.; Herwig, C.; Surzyn, M.; Walker, B.; Marison, I.; von Stockar, U. Generally applicable fed-batch culture concept based on the detection of metabolic state by on-line balancing. Biotechnol. Bioeng. 2003, 82 (6), 627- 639.
29. Wilms, B.; Hauck, A.; Reuss, M.; Syldatk, C.; Mattes, R.; Siemann, M.; Altenbuchner, J. High-cell-density fermentation for production of L-N-carbamoylase using an expression system based on the Escherichia coli rhaBAD promoter. Biotechnol. Bioeng. 2001, 73 (2), 95-103.
30. Baneyx, F.; Mujacic, M. Recombinant protein folding and misfolding in Escherichia coli. Nat. Biotechnol. 2004, 22 (11), 1399 -1408.
31. Andersson, L.; Yang, S.; Neubauer, P.; Enfors, S. O. Impact of plasmid presence and induction on cellular responses in fed batch cultures of Escherichia coli. J. Biotechnol. 1996, 46 (3), 255-263.
32. Tong, L. Extracellular expression, purification, and characterization of a winter flounder antifreeze polypeptide from Escherichia coli. Protein Expr. Purif. 2000, 18 (2), 175-181.
33. Corchero, J. L.; Cubarsí, R.; Vila, P.; Arís, A.; Villaverde, A. Cell lysis in Escherichia coli cultures stimulates growth and biosynthesis of recombinant proteins in surviving cells. Microbiol. Res. 2001, 156 (1), 13-18.
34. Sommer, B.; Friehs, K.; Flaschel, E. Efficient production of extracellular proteins with Escherichia coli by means of optimized coexpression of bacteriocin release proteins. J. Biotechnol. 2010, 145 (4), 350 -358.
35. Andersson, L.; Strandberg, L.; Enfors, S.-O. Cell segregation and lysis have profound effects on the growth of Escherichia coli in high cell density fed batch cultures. Biotechnol. Prog. 1996, 12 (2), 190 -195.
36. Sandén, A. M.; Prytz, I.; Tubulekas, I.; Förberg, C.; Le, H.; Hektor, A.; Neubauer, P.; Pragai, Z.; Harwood, C.; Ward, A.; Picon, A.; De Mattos, J. T.; Postma, P.; Farewell, A.; Nyström, T.; Reeh, S.; Pedersen, S.; Larsson, G. Limiting factors in Escherichia coli fed-batch production of recombinant proteins. Biotechnol. Bioeng. 2003, 81 (2), 158 -166.
37. Glick, B. R. Metabolic load and heterologous gene expression. Biotechnol. Adv. 1995, 13 (2), 247-261.
38. Birnbaum, S.; Bailey, J. E. Plasmid presence changes the relative levels of many host cell proteins and ribosome components in recombinant Escherichia coli. Biotechnol. Bioeng. 1991, 37 (8), 736 -745.
39. Voellmy, R.; Goldberg, A. L. Guanosine-5″-diphosphate-3″- diphosphate (ppGpp) and the regulation of protein breakdown in Escherichia coli. J. Biol. Chem. 1980, 255 (3), 1008 -1014.
40. Farewell, A.; Neidhardt, F. C. Effect of temperature on in vivo protein synthetic capacity in Escherichia coli. J. Bacteriol. 1998, 180 (17), 4704-4710.
41. Landgrebe, D.; Haake, C.; Höpfner, T.; Beutel, S.; Hitzmann, B.; Scheper, T.; Rhiel, M.; Reardon, K. F. On-line infrared spectroscopy for bioprocess monitoring. Appl. Microbiol. Biotechnol. 2010, 88 (1), 11-22.
42. C. Dietzsch, O. Spadiut, C. Herwig, On-line multiple component analysis for efficient quantitative bioprocess development. J. Biotechnol. 2012, in press.